Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
10.79
+0.65 (6.41%)
Jun 29, 2026, 4:00 PM EDT - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $509.65 million as of June 29, 2026. Its market cap has increased by 93.21% in one year.
Market Cap
509.65M
Enterprise Value
439.71M
1-Year Change
93.21%
Ranking
Category
Stock Price
$10.79
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $509.65M, a decrease of -5.33%. That is a compound annual growth rate of -0.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 509.65M | 77.47% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 513.11M |
| Zura Bio | 508.24M |
| Ocugen | 507.78M |
| Neurogene | 506.13M |
| Sutro Biopharma | 505.73M |
| Cabaletta Bio | 495.69M |
| Shattuck Labs | 493.82M |
| Valneva SE | 482.77M |